Jagiellońskie Centrum Innowacji Sp. z o.o.

The medical center is at the forefront of rheumatology research, particularly focusing on knee osteoarthritis. The center's studies aim to understand the impact of treatments like naproxen sodium on synovial fluid and inflammatory markers such as Interleukin-6 (IL-6).

• Synovial fluid analysis
• Inflammatory cytokine modulation
• Non-steroidal anti-inflammatory drugs (NSAIDs)

These investigations contribute to improved therapeutic strategies for managing osteoarthritis symptoms and enhancing patient quality of life.

Specializing in oncology, the center conducts pivotal research on various cancers, including platinum-sensitive epithelial ovarian cancer and papillary renal cell carcinoma. The focus is on innovative therapies like mirvetuximab soravtansine and savolitinib to improve progression-free survival rates.

• Targeted cancer therapies
• Progression-free survival metrics
• Combination drug regimens

These efforts are crucial in developing personalized treatment plans and advancing cancer care.

The center is renowned for its research in dermatology, focusing on conditions like acne vulgaris and prurigo nodularis. Studies explore the efficacy and safety of novel topical treatments, such as N-Acetyl-GED-0507-34-Levo gel and povorcitinib.

• Topical drug development
• Long-term safety assessments
• Itch and lesion management

This research is instrumental in enhancing therapeutic options and improving patient outcomes in dermatological care.

Focusing on immunology, the center investigates treatments for autoimmune conditions such as plaque psoriasis. Research includes evaluating the efficacy of innovative therapies like JNJ-77242113 to manage moderate to severe cases.

• Autoimmune disease management
• Biologic and small molecule therapies
• Clinical efficacy trials

These studies are pivotal in advancing understanding and treatment of autoimmune disorders.

The center excels in gynecologic oncology, with research targeting cervical cancer and high-grade serous ovarian cancer. The focus is on assessing the safety and efficacy of treatments like volrustomig and ZN-c3.

• Advanced cancer therapies
• Safety and tolerability studies
• Antitumor activity evaluation

This research is vital for developing effective treatment protocols and improving survival rates in gynecologic cancers.